4/A

FORM 4/A SUBMISSION

Company: Vanda Pharmaceuticals Inc.
Filed: July 20, 2012
Period of Report: February 16, 2012
Accession Number: 0001209191-12-038757

View Document ↗ View on SEC.gov ↗